Uridine 5'-triphosphate Completed Phase 2 Trials for Lung Cancer Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs
NCT00008255INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer